The OLS has just launched the Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk You can find out more details about the fund at this webpage
Read our other news
New technology will help improve safety for road workers across the UK
The University of Chester’s new home of medical sciences has been officially opened by chancellor Dame Jenny Harries, after extensive refurbishment work was completed
A leading solicitor from Aaron & Partners has been appointed chair of the North West region of R3, the UK’s trade body for restructuring, insolvency and turnaround professionals